Skip to content

Effect of Rhythmic Upper-limb Training in Stroke Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02139553
Enrollment
14
Registered
2014-05-15
Start date
2014-05-31
Completion date
2016-06-30
Last updated
2017-01-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Stroke

Keywords

Rhythmic versus discrete movements, Rehabilitation

Brief summary

The purpose of this study is to determine whether rhythmic upper-limb movement training in post-stroke patients allows to improve only this particular type of movements or if it also improves some parameters of discrete movements. Based on our results we hope to be able to answer a fundamental question: are rhythmic and discrete movements two independent primitives?

Detailed description

Patients are assessed four times during this longitudinal study. One month separates the first two assessment, next patients are trained 12 times during one month with rhythmic movement training on an end-effector robot. After this month, patients are assessed a third time and three months later a fourth time in order to study long-time benefits of the therapy.

Interventions

PROCEDURERhythmic rehabilitation

Stroke patients have 12 rehabilitation sessions on a planar rehabilitation robot, Reaplan, focussed on rhythmic arm movements.

Sponsors

Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* more than 6 months post-stroke patients * Fugl-Meyer between 7 and 55 * Maintain the same intensity of rehabilitation during the study

Exclusion criteria

* cerebellar stroke * severe aphasia or cognitive disorder * any other neurological disorder

Design outcomes

Primary

MeasureTime frameDescription
Change in movement smoothness in rhythmic straight movements after one month of rhythmic therapy1 week to 1 day before therapy and 1 day to 1 week after therapyPatients are asked to fulfill rhythmic movements on the end-effector robot Reaplan. The smoothness is assessed with following metrics: * number of peaks in velocity profile * TENT value * logarithmic dimensionless square jerk
Change in movement smoothness in discrete straight movements after one month of rhythmic therapy1 week to 1 day before therapy and 1 day to 1 week after therapyPatients are asked to fulfill discrete movements on the end-effector robot Reaplan. The smoothness is assessed with following metrics: * number of peaks in velocity profile * TENT value * logarithmic dimensionless square jerk
Change in accuracy of discrete straight movements after one month of rhythmic therapy1 week to 1 day before therapy and 1 day to 1 week after therapyPatients are asked to fulfill discrete movements on the end-effector robot Reaplan. The accuracy is assessed.
Change in smoothness of rhythmic circular movement after rhythmic therapy1 day to 1 week before therapy and 1day to 1 week after therapyPatients are asked to fulfill 10 circular movements on the end-effector robot Reaplan. The movement smoothness are assessed

Secondary

MeasureTime frameDescription
Therapy after effects1 day to one week after therapy and 3 months after therapyEvolution of the movement smoothness in rhythmic and discrete movements, the movement accuracy in discrete movements and the general motricity
Assessment of the natural evolution of the patient4 to 5 weeks before therapy and 1 week to 1 day before therapyNatural evolution of the movement smoothness in rhythmic and discrete movements, of the accuracy in discrete movements and of the general motricity of the patient
Change of the general motricity of the patient due to one month rhythmic therapy1 week to 1 day before therapy and 1 day to 1 week after therapy1. Upper limb Fugl-Meyer Assessment 2. Box and block test 3. Ashworth test

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026